Clifford Capital Partners LLC increased its position in shares of Dolby Laboratories (NYSE:DLB – Free Report) by 14.2% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 347,520 shares of the electronics maker’s stock after acquiring an additional 43,209 shares during the quarter. Dolby Laboratories accounts for about 3.8% of Clifford Capital Partners LLC’s holdings, making the stock its 8th largest position. Clifford Capital Partners LLC’s holdings in Dolby Laboratories were worth $22,318,000 at the end of the most recent reporting period.
Several other hedge funds have also recently bought and sold shares of the business. Aristotle Capital Boston LLC lifted its stake in Dolby Laboratories by 12.3% in the 4th quarter. Aristotle Capital Boston LLC now owns 192,483 shares of the electronics maker’s stock worth $12,361,000 after acquiring an additional 21,125 shares in the last quarter. Balyasny Asset Management L.P. lifted its stake in Dolby Laboratories by 323.4% in the 4th quarter. Balyasny Asset Management L.P. now owns 190,659 shares of the electronics maker’s stock worth $12,244,000 after acquiring an additional 145,630 shares in the last quarter. Boothbay Fund Management LLC purchased a new stake in Dolby Laboratories in the 4th quarter worth about $274,000. Freestone Grove Partners LP purchased a new stake in Dolby Laboratories in the 4th quarter worth about $718,000. Finally, Guggenheim Capital LLC purchased a new stake in Dolby Laboratories in the 4th quarter worth about $260,000. 58.56% of the stock is owned by hedge funds and other institutional investors.
Dolby Laboratories Price Performance
DLB opened at $51.19 on Thursday. Dolby Laboratories has a fifty-two week low of $51.08 and a fifty-two week high of $77.00. The business has a 50-day moving average of $57.83 and a 200-day moving average of $61.86. The company has a market capitalization of $4.84 billion, a PE ratio of 20.23 and a beta of 0.81.
Dolby Laboratories Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Wednesday, May 20th. Stockholders of record on Tuesday, May 12th were paid a dividend of $0.36 per share. The ex-dividend date of this dividend was Tuesday, May 12th. This represents a $1.44 dividend on an annualized basis and a dividend yield of 2.8%. Dolby Laboratories’s dividend payout ratio (DPR) is 56.92%.
Insider Transactions at Dolby Laboratories
In other news, SVP John D. Couling sold 7,666 shares of the firm’s stock in a transaction dated Monday, June 1st. The stock was sold at an average price of $55.62, for a total transaction of $426,382.92. Following the completion of the sale, the senior vice president directly owned 118,727 shares of the company’s stock, valued at $6,603,595.74. This trade represents a 6.07% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Robert J. Park sold 4,895 shares of the firm’s stock in a transaction that occurred on Tuesday, May 12th. The shares were sold at an average price of $56.68, for a total value of $277,448.60. Following the completion of the transaction, the chief financial officer directly owned 81,490 shares in the company, valued at $4,618,853.20. The trade was a 5.67% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 39,791 shares of company stock valued at $2,231,653 over the last 90 days. Company insiders own 37.93% of the company’s stock.
Wall Street Analysts Forecast Growth
Several equities research analysts recently issued reports on DLB shares. Wall Street Zen raised Dolby Laboratories from a “hold” rating to a “buy” rating in a research note on Saturday, May 30th. Weiss Ratings reissued a “hold (c-)” rating on shares of Dolby Laboratories in a research note on Friday, March 27th. Barrington Research reissued an “outperform” rating and issued a $90.00 price objective on shares of Dolby Laboratories in a research note on Monday. Finally, Rosenblatt Securities reissued a “buy” rating and issued a $85.00 price objective on shares of Dolby Laboratories in a research note on Thursday, June 11th. Three equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat.com, Dolby Laboratories has a consensus rating of “Moderate Buy” and a consensus price target of $90.75.
View Our Latest Research Report on DLB
Dolby Laboratories Profile
Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.
Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.
Recommended Stories
- Five stocks we like better than Dolby Laboratories
- Cheap Thrills: Why These 3 Entertainment Stocks Are Soaring
- CoreWeave Insider Sales Look Big, But Should Investors Worry?
- Critical Metals: Sizing Up This Tiny Rare-Earth Stock Making Big Moves
- Meta and Cloud Computing: Real Potential, or a Shot in the Dark?
Want to see what other hedge funds are holding DLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dolby Laboratories (NYSE:DLB – Free Report).
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
